FDA Investigator Syeda N Mahazabin
Syeda N Mahazabin has conducted inspections on 26 sites in 2 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
26
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China
FDA Investigators that have inspected at least one site in common with Syeda N Mahazabin:
Alice S Tsao,
Amatul H Marium,
Anastasia M Shields,
Anita R Michael,
Ankur C Patel,
Ann M Stewart,
Anthony J Donato,
Aziz A Mamur,
Benton M Ketron,
Bijoy Panicker,
Brandy N Lepage,
Bruce G Cooper,
Carolyn J Cook,
Charisse K Green,
Christina K Theodorou,
Christopher S Fields,
Cynthia A Palmer,
Dana A Razzano,
Daniel L Aisen,
Daniel R Tammariello,
David A Carlson,
David M Mcnew,
David R Delucia,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Devon Jenkins,
Dr. Robert C Horan, MD,
Edwin Melendez,
Erica B Raphael,
Evan Tong,
Frederick F Razzaghi,
Gam S Zamil,
Geoffrey K Wong,
George C Amedro,
Gladys B Casper,
Hala L Selby,
Harry J Brewer,
Helen B Ricalde,
Heriberto Negron Rivera,
Iram R Hassan, PhD,
Jacqueline S Warner,
James A Liubicich,
James D Bridges,
James M Mason,
James M Odonnell,
James R Birkenstamm,
Jay T Wong,
Jeanette L Mcginnis,
Joanne M Schlossin,
John A Podsadowski,
Johnna L Bleem,
Jose Ohernandez Guzman,
Joseph J Vannelli,
Joy P Matthias,
Juliana M Badalucco,
Julianne C Mccullough,
Junho Pak,
Karen F Tomaziefski,
Karen L Kosar,
Katelyn Astaub Zamperini,
Kendra L Brooks,
Kenneth G Klobus,
Kevin A Gonzalez,
Kim M Downing,
Kimberley A Ricketts,
Ko U Min,
Kwong P Lee,
Lauren E Blaser,
Lawrence Harmon, Jr,
Lawrence W Farina,
Linda M Sacco,
Loretta Nemchik,
Margaret E Sarles,
Margaret M Sands,
Maria A Reed,
Maria Estrella,
Marie Elena C Puleo,
Marlene L Davis,
Matthew A Spataro,
Matthew D Schnittker,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael Levin,
Michael W Burd,
Mindy M Chou,
Monika Borkowska,
Nancy M Espinal,
Neil J Bonzagni, PhD MPH,
Nicholas A Violand,
Nicholas C Mendiola,
Niketa Patel,
Nina Yang,
Paige R Mccoy,
Parul M Patel,
Patricia A Clark,
Patrick C Klotzbuecher,
Paul E Stein,
Paul L Bellamy,
Paul Mouris,
Perry T Nichols,
Rachael A Moliver,
Richard K Glabach,
Robert C Steyert,
Rochelle K Kimmel,
Rose Ljean Mary,
Ruben C Quintana,
Russ E Davis,
Russell J Glapion,
Samina S Khan,
Samuel T Walker,
Sasha M Latonis,
Satheesh Thomas,
Sayyem H Akbar,
Shari L Kahn,
Shirley J Berryman,
Simone E Pitts,
Sony Mathews,
Susan F Laska, MS,
Tammy S Notto,
Tanya R Syffrard,
Thomas J Mooney,
Thomas P Hansen,
Todd J Maushart,
Tonia F Bernard,
Tracey L Harris,
Uduak M Inokon,
Vanessa M Williams,
Victoria Spivak,
Vivin George,
Vlada Matusovsky,
William J Leonard,
Xiaoping Guan,
Yvesna C Blaise,
Zhongren Wu,
Zi Qiang Gu
Syeda N Mahazabin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more